Here's the live share price of Chandra Bhagat Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Chandra Bhagat Pharma has gained 4.68% CAGR. Over the past year, the corresponding return has been -39.77%.
Chandra Bhagat Pharma’s current P/E of 21.01x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Chandra Bhagat Pharma | -13.64 | -25.42 | -22.12 | -32.31 | -39.77 | -25.46 | 4.68 |
Sun Pharmaceutical Industries | 0.99 | -1.32 | -4.43 | -5.58 | -13.53 | 22.86 | 25.44 |
Divi's Laboratories | 1.35 | -1.39 | -9.09 | 7.26 | 10.98 | 19.38 | 13.39 |
Cipla | 0.28 | -0.53 | 1.92 | 4.23 | -6.24 | 14.18 | 15.63 |
Torrent Pharmaceuticals | -2.95 | -3.25 | 7.81 | 15.50 | 2.38 | 33.75 | 19.96 |
Dr. Reddy's Laboratories | 1.32 | 3.70 | -2.69 | 13.92 | -1.44 | 17.09 | 7.19 |
Mankind Pharma | -0.83 | 3.97 | 8.45 | 18.23 | 4.55 | 21.72 | 12.52 |
Zydus Lifesciences | -0.29 | 4.77 | 6.12 | 15.71 | -7.35 | 42.05 | 21.62 |
Lupin | 4.71 | 4.15 | 2.02 | 3.02 | -8.93 | 48.04 | 14.81 |
Abbott India | 1.23 | -4.93 | -2.02 | 2.81 | 6.44 | 20.90 | 13.41 |
Alkem Laboratories | 3.35 | 3.02 | 13.21 | 14.40 | -13.33 | 20.01 | 14.29 |
Aurobindo Pharma | 4.59 | 0.18 | -4.54 | -1.88 | -30.10 | 26.95 | 5.60 |
Glenmark Pharmaceuticals | -1.88 | 5.17 | 23.41 | 45.12 | 19.22 | 77.31 | 32.95 |
Laurus Labs | -0.79 | 3.44 | 31.66 | 53.95 | 77.42 | 20.10 | 27.14 |
Biocon | -1.25 | -1.13 | 0.78 | 7.85 | -7.84 | 7.35 | -3.86 |
Anthem Biosciences | 1.45 | 3.75 | 13.75 | 13.75 | 13.75 | 4.39 | 2.61 |
GlaxoSmithKline Pharmaceuticals | -2.60 | -1.60 | -18.46 | 1.95 | -3.00 | 24.23 | 9.16 |
Cohance Lifesciences | -2.90 | 10.08 | -0.45 | -12.87 | -15.54 | 28.96 | 21.52 |
Gland Pharma | 5.31 | 2.52 | 14.26 | 30.13 | 8.35 | -4.11 | 2.12 |
Ipca Laboratories | -0.61 | -5.32 | -3.76 | -0.34 | -10.15 | 14.97 | 3.52 |
Over the last one year, Chandra Bhagat Pharma has declined 39.77% compared to peers like Sun Pharmaceutical Industries (-13.53%), Divi's Laboratories (10.98%), Cipla (-6.24%). From a 5 year perspective, Chandra Bhagat Pharma has underperformed peers relative to Sun Pharmaceutical Industries (25.44%) and Divi's Laboratories (13.39%).
Day | SMA | EMA |
---|---|---|
5 | 49.91 | 48.25 |
10 | 52.66 | 50.44 |
20 | 54.55 | 52.77 |
50 | 56.72 | 56.54 |
100 | 62.1 | 62.52 |
200 | 75.95 | 73.69 |
In the latest quarter, Chandra Bhagat Pharma saw a rise in promoter holding to 71.20%, while DII stake unchanged at 0.00%, FII holding rose to 0.61%, and public shareholding moved down to 28.18% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 06, 2025, 10:38 PM IST | Chandra Bhagat Pharm - Reg. 34 (1) Annual Report. |
Sep 06, 2025, 10:34 PM IST | Chandra Bhagat Pharm - Notice Of Shareholders Meeting Held On September 30, 2025. |
Sep 06, 2025, 10:30 PM IST | Chandra Bhagat Pharm - Board Meeting Outcome for Outcome Of The Board Meeting Held On September 06,2025. |
May 30, 2025, 3:08 AM IST | Chandra Bhagat Pharm - Appointment Of Secretarial Auditor. |
May 30, 2025, 2:30 AM IST | Chandra Bhagat Pharm - Result For The Financial Year March 31, 2025. |
Chandra Bhagat Pharma Ltd. is a Public Limited Listed company incorporated on 10/03/2003 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH2003PLC139534 and registration number is 139534. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 86.72 Cr. and Equity Capital is Rs. 7.55 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Chandra Bhagat Pharma is ₹44.00 as on Sep 15, 2025.
The Chandra Bhagat Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Chandra Bhagat Pharma is ₹33.20 Cr as on Sep 15, 2025.
Today’s highest and lowest price of Chandra Bhagat Pharma are ₹44.01 and ₹44.00.
The 52-week high/low is the highest and lowest price at which Chandra Bhagat Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Chandra Bhagat Pharma is ₹80.00 and 52-week low of Chandra Bhagat Pharma is ₹44.00 as on Sep 15, 2025.
The Chandra Bhagat Pharma has shown returns of 0.0% over the past day, -25.42% for the past month, -22.12% over 3 months, -39.77% over 1 year, -25.46% across 3 years, and 4.68% over 5 years.
P/E ratio of and PB ratio of Chandra Bhagat Pharma are 21.01 and 1.11 on Sep 15, 2025. While the company gives a dividend yield of 0.00 per annum.